| MR编号 | SE/H/1921/003 |
|---|
| 药品名称 | Flutiform |
|---|
| 活性成分 | - fluticasone propionate 250.0 µg
- formoterol fumarate 10.0 µg
|
|---|
| 剂型 | Pressurised inhalation, suspension |
|---|
| 上市许可持有人 | Mundipharma AB
Sweden |
|---|
| 参考成员国 - 产品名称 | Sweden (SE) |
|---|
| 互认成员国 - 产品名称 | - Portugal (PT)
- Italy (IT)
- Norway (NO)
- Finland (FI)
- Bulgaria (BG)
Affilia - Cyprus (CY)
Affilia 250 micrograms / 10 micrograms Pressurised inhalation suspension - Czechia (CZ)
AFFILIA - Slovakia (SK)
Flutiform 250 mikrogramov/10 mikrogramov - Croatia (HR)
- Slovenia (SI)
- France (FR)
- Spain (ES)
- Germany (DE)
Affilia 250 µg/10 µg Druckgasinhalation, Suspension - Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
Affilia - Iffeza - Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- Austria (AT)
Flutiform 250 Mikrogramm/10 Mikrogramm pro Sprühstoß Druckgasinhalation, Suspension
|
|---|
| 许可日期 | 2012/09/12 |
|---|
| 最近更新日期 | 2024/03/07 |
|---|
| 药物ATC编码 | - R03AK07 formoterol and budesonide
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：[not specified]
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|